FMT for Remission of Active Ulcerative Colitis in Adults

Exclusion Criteria

• •Planned or actively taking another investigational product
• •Abdominal surgery within the past 60 days
• •Patients with neutropenia with absolute neutrophil count \<0.5 x 109/L at - Evidence of toxic megacolon or gastrointestinal perforation on imaging
• •Peripheral white blood cell count \> 35.0 x 109/L at enrollment AND temperature \> 38.0oC
• •Active infectious diarrhea at the time of enrolment
• •Increase in medical therapy for UC within 3 months of enrollment. Continued treatment with stable dose of 5-ASA, azathioprine, 6-mercaptopurine, cyclosporine, prednisone and/or anti- TNF agents for at least 3 months of is allowed
• •Severe UC requiring hospitalization at the time of enrolment
• •Pregnant or lactating
• •History of anaphylaxis to any food
• •Requiring oral and/or intravenous systemic antibiotic therapy at the time of study enrolment
• •Unwilling to discontinue probiotic (yogurt is allowed)
• •Severe underlying disease such that the patient is not expected to survive for at least 30 days.
• •Any condition that in the opinion of the investigator that would pose harm to the participant or the research staff for the potential participant to take part in the trial